The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

| Factor | Score | Distribution | Value | Avg | Verdict |
|---|---|---|---|---|---|
Valuation | 49 | — | 20.1x | Near average | |
Growth | 74 | 17.8% | 5.6% | Above average | |
Quality | 31 | -49.8% | 7.6% | Below average | |
Safety | 75 | 1.1x | 0.4x | Above average | |
Capital Return | 41 | — | 2.19% | Near average | |
Momentum | — | — | — | No data | |
Sentiment | — | — | — | No data |
Twist Bioscience Corporation is a publicly traded stock representing ownership in the company, giving holders rights to dividends and voting.
You can buy Twist Bioscience Corporation shares through a licensed brokerage. Research the company's financials before investing.
Key metrics include Price-to-Earnings (P/E) ratio, Return on Equity (ROE), revenue growth, and net profit margin.
Dividend policies vary by company. Check the dividends section on the stock page for the payout history.
Risks include market volatility, sector-specific risks, regulatory changes, and company financial performance. Diversification helps reduce risk.
AI analysis from the earnings call, financials and news
This section combines price targets, revision history, analyst coverage changes, and an AI summary of what changed on the Street.
Twist Bioscience stock shows remarkable stability in analyst estimates over the past 30 days, with the average price target stabilizing at 64.4 dollars based on a consensus of 6 analysts. The current price (60.57 dollars) reflects proximity to the median price target (65 dollars), indicating that the stock is trading near its fair value according to current estimates without any recent upward or downward revisions.
Ten ratios that matter, each compared against its sector median and average — so you can see whether a number is rich or cheap relative to peers in the same sector.